Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3(+) inflammatory cells.
- DOI
- 10.1016/j.yjmcc.2026.08.010
- Published
- 2026 Oct
- Container
- Journal of molecular and cellular cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.yjmcc.2026.08.010,
title = {Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3(+) inflammatory cells.},
author = {Liu L and Niu W and Jia Y and Zhang Q and Dai T and Li D and Song S and Ma Y and Wang J and Yu H and Liu G and Du J and Wang L},
year = {2026},
journal = {Journal of molecular and cellular cardiology},
doi = {10.1016/j.yjmcc.2026.08.010},
url = {https://doi.org/10.1016/j.yjmcc.2026.08.010}
}RIS
TY - JOUR TI - Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3(+) inflammatory cells. AU - Liu L AU - Niu W AU - Jia Y AU - Zhang Q AU - Dai T AU - Li D AU - Song S AU - Ma Y AU - Wang J AU - Yu H AU - Liu G AU - Du J AU - Wang L PY - 2026 JO - Journal of molecular and cellular cardiology DO - 10.1016/j.yjmcc.2026.08.010 UR - https://doi.org/10.1016/j.yjmcc.2026.08.010 ER -
APA
L, L., W, N., Y, J., Q, Z., T, D., D, L., S, S., Y, M., J, W., H, Y., G, L., J, D., & L, W. (2026). Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3(+) inflammatory cells.. Journal of molecular and cellular cardiology. https://doi.org/10.1016/j.yjmcc.2026.08.010
Source records
- pubmed · retrieved 2026-09-26T22:41:42.519Z